Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-08-03

Clinical Trial Results: Semaglutide Treatment, Appetite, and Eating Behavior: Long-term Effects [Phase 4]

View source ↗

Summary

Phase 4 trial results on semaglutide for appetite and eating behavior with long-term effects in obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • semaglutide (semaglutide)

Snippet

Sponsor: University of Pennsylvania | Conditions: Obesity | Phase 4 | Status: COMPLETED | Results posted: 2026-08-03